Florida Approves 6.9% Workers’ Compensation Rate Cut for 2026

Construction workers on indoor scaffolding

Florida employers are getting another break on business expenses: the state has approved a 6.9% reduction in workers’ compensation insurance rates for 2026, marking the ninth consecutive year that rates have gone down.

Insurance Commissioner Mike Yaworsky officially signed off on the rate cut, which was proposed by the National Council on Compensation Insurance (NCCI). The decrease applies to all new and renewal workers’ comp policies beginning January 1, 2026.

Yaworsky noted the trend reflects Florida’s improvements in managing workplace risks and stabilizing insurance costs. “This rate decrease directly translates to reduced operating costs for businesses, encouraging investment and growth throughout Florida’s economy,” he said.

Why this matters for Florida professionals

• Lower operating costs for brokers, agencies, and real estate firms with payroll-based policies.

• Encourages hiring and expansion across construction, housing, and property management sectors.

• Extends a multi-year trend of easing statewide business expenses.

Dig deeper: official documents & hearings

• Watch the Florida OIR rate hearing recording: View the recorded session

• Review NCCI’s complete filing on the OIR website: Access filing details

• Read the original report from Islander News: Full article

With another rate reduction locked in, Florida businesses—from contractors to real estate brokerages—can expect additional breathing room in 2026 as statewide operational costs continue trending downward.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The AI Boom in Cancer: Game-Changer or Just Hype?

The promise of artificial intelligence (AI) in the field of oncology is nothing short of revolutionary. As the world grapples with the complexities of cancer, AI is emerging as a potential game-changer in diagnostics, treatment personalization, and drug discovery.

By |January 15, 2025|Categories: Article, Healthcare, Technology|Tags: |0 Comments

HHS Unveils AI Strategic Plan to Revolutionize Healthcare

The U.S. Department of Health and Human Services (HHS) has unveiled its ambitious AI Strategic Plan, a comprehensive blueprint aimed at revolutionizing healthcare, human services, and public health through the transformative power of artificial intelligence.

By |January 15, 2025|Categories: Article, Artificial Intelligence, Healthcare|Tags: , |0 Comments

United States Naval Academy Class of 2024 Graduation

The ceremony was graced by the presence of three distinguished speakers, whose words of wisdom and encouragement left a lasting impression on the attendees.

By |January 14, 2025|Categories: Article, Education, Military|Tags: , |0 Comments

AI Certifications: The Key to Future-Proofing Your Career

In the fast-paced world of artificial intelligence (AI), staying current with the latest technological advancements is crucial for professionals aiming to excel in their careers. As businesses increasingly integrate AI into their operations, the demand for skilled AI experts is surging.

By |January 14, 2025|Categories: Article, Education, Technology|Tags: , |0 Comments

Telemedicine: A Digital Revolution in Healthcare Amid COVID-19

The year 2020 marked a significant turning point in the global healthcare landscape, as the COVID-19 pandemic accelerated the adoption of digital technologies such as telemedicine.

By |January 14, 2025|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Genomic Biomarkers Market Thrives with Personalized Medicine Boom

The genomic biomarkers market is witnessing a significant surge, driven by the burgeoning demand for personalized medicine. According to the latest report, the market is projected to grow to $14.09 billion by 2028, marking a compound annual growth rate (CAGR) of 17.4%. This approach not only optimizes treatment effectiveness but also minimizes side effects, making it a cornerstone of modern healthcare.